诺和诺德剥离糖尿病资产给Aspect,细胞疗法领域战略收缩。
Novo Nordisk offloads diabetes assets to Aspect amid cell therapy retreat
生物技术与制药领域的最新动态
Novo Nordisk offloads diabetes assets to Aspect amid cell therapy retreat
Novacell Technology reports new FPR2 agonists
Anti-resonance in developmental signaling regulates cell fate decisions
cxcl18b-defined transitional state-specific nitric oxide drives injury-induced Müller glia cell-cycle re-entry in the zebrafish retina
The Bull Case For Illumina (ILMN) Could Change Following Its Billion Cell Atlas Pharma Alliance - Yahoo Finance Singapore
Identification of a sub-population of synovial mesenchymal stem cells with enhanced treatment efficacy in a rat model of osteoarthritis
Single-cell profiling of trabecular meshwork identifies mitochondrial dysfunction in a glaucoma model that is protected by vitamin B3 treatment
Human genetics guides the discovery of CARD9 inhibitors with anti-inflammatory activity
Nanoparticles hijack calvarial immune cells for CNS drug delivery and stroke therapy
Continuum architecture dynamics of vesicle tethering in exocytosis
Multimodal supramolecular targeting chimeras enable spatiotemporally resolved protein degradation in vivo
ImmunityBio's cell therapy posts encouraging early data in rare blood cancer
Scientists turn cells’ most mysterious structures into spies on genetic activity
Your Media Choice Might Be Designing Your T-Cell Fate
EBV infection and HLA-DR15 jointly drive multiple sclerosis by myelin peptide presentation
Myelin antigen capture in the CNS by B cells expressing EBV latent membrane protein 1 leads to demyelinating lesion formation
Anoctamin-2-specific T cells link Epstein-Barr virus to multiple sclerosis
JPM26: Paying cash for obesity drugs, renewed IPO optimism and pharma’s cell therapy view
Illumina unveils massive cell atlas to speed up drug discovery - San Diego Union-Tribune
Afadin sorts different retinal neuron types into accurate cellular layers